Luxbright (LXB) H2 2024 earnings summary

Executive summary

• 2024 marked a breakthrough year with over 9 MSEK in net sales, strong order book, and successful commercialization of new X-ray products.

• Strategic partnerships, especially with Fisica Inc., and new product launches like Luxbright IX1 and MF1 drove growth.

• The company is positioned for further expansion in 2025, focusing on global sales, production capacity, and innovation.

Financial highlights

• Net sales for Jan–Dec 2024 reached 9,022 KSEK, up from 855 KSEK year-over-year; H2 sales were 5,674 KSEK.

• Operating result for Jan–Dec improved to -18,059 KSEK from -26,034 KSEK; H2 operating result was -8,777 KSEK.

• EPS for Jan–Dec was -0.17 SEK (vs. -0.37 SEK); H2 EPS was -0.07 SEK (vs. -0.14 SEK).

• Cash flow from operations was -16,515 KSEK; total cash flow for the year was -1,684 KSEK.

• Equity at year-end was 34,197 KSEK; cash and equivalents were 12,355 KSEK.

Outlook and guidance

• Management expects strong growth and expansion in 2025, leveraging a solid order book and global partnerships.

• No quantified forecast for 2025; potential need for additional financing is under discussion.